What's new

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised

Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised

May 28, 2025 - 17:35
 0
Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised
Human medicines European public assessment report (EPAR): Xolair, omalizumab, Date of authorisation: 25/10/2005, Revision: 52, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Truxima, rituximab, Da...

Next Article

Nitrosamine impurities: guidance for marketing authorisation holders

Related Posts

Human medicines European public assessment report (EPAR): Faslodex, fulvestrant, Date of authorisation: 09/03/2004, Revision: 26, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0

PSUSA/00001603/202408

PSUSA/00001603/202408

May 28, 2025  0

Human medicines European public assessment report (EPAR): Tevimbra, tislelizumab, Date of authorisation: 15/09/2023, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 15, 2025  0